Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017

Alireza Esteghamati

Alireza Esteghamati

Professor of Endocrinology & Metabolism

Department Internal Medicine

School of Medicine

Imam Khomeini Hospital Complex

Psychosomatic Medicine Research Center

Tehran University of Medical Sciences

Related Documents

1. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)

2. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)

3. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)

4. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

5. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)

6. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

7. Incident Type 2 Diabetes Attributable to Suboptimal Diet in 184 Countries, Nature Medicine (2023)

8. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)

9. Measuring the Health-Related Sustainable Development Goals in 188 Countries: A Baseline Analysis From the Global Burden of Disease Study 2015, The Lancet (2016)

All Documents

1. Author Correction: Burdens of Type 2 Diabetes and Cardiovascular Disease Attributable to Sugar-Sweetened Beverages in 184 Countries (Nature Medicine, (2025), 10.1038/S41591-024-03345-4), Nature Medicine (2025)

2. Burdens of Type 2 Diabetes and Cardiovascular Disease Attributable to Sugar-Sweetened Beverages in 184 Countries, Nature Medicine (2025)

3. Impact of Bariatric Surgery on Liver Fibrosis Indices Among Type 2 Diabetes Patients in a National Cohort, Scientific Reports (2025)

4. The Trend of Atherogenic Indices in Patients With Type 2 Diabetes After Bariatric Surgery: A National Cohort Study, Surgery for Obesity and Related Diseases (2025)

5. Associations of Major Dietary Patterns With Cardiometabolic Risk Factors Among Iranian Patients With Type 1 Diabetes, Preventive Medicine Reports (2024)

6. Associations of Major Dietary Patterns With Cardiometabolic Risk Factors Among Iranian Patients With Type 1 Diabetes, Preventive Medicine Reports (2024)

7. Correlates of Normal and Decreased Hdl Cholesterol Levels in Type 2 Diabetes: A Cohort-Based Cross-Sectional Study, Lipids in Health and Disease (2024)

8. Effects and Safety of Resveratrol Supplementation in Older Adults: A Comprehensive Systematic Review, Phytotherapy Research (2024)

9. How Prices and Income Influence Global Patterns in Saturated Fat Intake by Age, Sex and World Region: A Cross-Sectional Analysis of 160 Countries, BMJ Open (2024)

10. Impact of Gender on Chronic Complications in Participants With Type 2 Diabetes: Evidence From a Cross-Sectional Study, Endocrinology# Diabetes and Metabolism (2024)

11. Iranian Patients With Diabetes and Covid-19-Associated Mucormycosis: Characteristics, Manifestations, and Mortality Risk Factors, International Journal of Diabetes in Developing Countries (2024)

12. Association of Major Dietary Patterns With Advanced Glycation End Products and High-Sensitivity C-Reactive Protein in People With Type 1 Diabetes Mellitus, Nutrition Journal (2023)

13. Association of Major Dietary Patterns With Advanced Glycation End Products and High-Sensitivity C-Reactive Protein in People With Type 1 Diabetes Mellitus, Nutrition Journal (2023)

14. Author Correction: Global Dietary Quality in 185 Countries From 1990 to 2018 Show Wide Differences by Nation, Age, Education, and Urbanicity (Nature Food, (2022), 3, 9, (694-702), 10.1038/S43016-022-00594-9), Nature Food (2023)

15. Author Correction: Global Dietary Quality in 185 Countries From 1990 to 2018 Show Wide Differences by Nation, Age, Education, and Urbanicity (Nature Food, (2022), 3, 9, (694-702), 10.1038/S43016-022-00594-9), Nature Food (2023)

16. Bilateral Inferior Petrosal Sinus Sampling: Validity, Diagnostic Accuracy in Lateralization of Pituitary Microadenoma, and Treatment in Eleven Patients With Cushing’S Syndrome – a Single-Center Retrospective Cohort Study, BMC Endocrine Disorders (2023)

17. Challenges to Lifestyle Medicine for Type 2 Diabetes in Iran: A Synoptic Review, American Journal of Lifestyle Medicine (2023)

18. Children’S and Adolescents’ Rising Animal-Source Food Intakes in 1990–2018 Were Impacted by Age, Region, Parental Education and Urbanicity, Nature Food (2023)

19. Children’S and Adolescents’ Rising Animal-Source Food Intakes in 1990–2018 Were Impacted by Age, Region, Parental Education and Urbanicity, Nature Food (2023)

20. Comparison of Insulin Resistance Indices in Predicting Albuminuria Among Patients With Type 2 Diabetes, European Journal of Medical Research (2023)

21. Correlation Between Different Levels and Patterns of Dyslipidemia and Glomerular Filtration Rate in Patients With Type 2 Diabetes: A Cross-Sectional Survey of a Regional Cohort, Journal of Clinical Laboratory Analysis (2023)

22. Decreasing Trend of Blood Lipid Profile in Type 2 Diabetes: Not a Promising Change in Hdl-C, a Serial Cross-Sectional Study, PLoS ONE (2023)

23. Development and Validation of a Risk Score for Diabetic Kidney Disease Prediction in Type 2 Diabetes Patients: A Machine Learning Approach, Journal of Endocrinological Investigation (2023)

24. Efficacy and Safety of a Biosimilar Liraglutide (Melitide®) Versus the Reference Liraglutide (Victoza®) in People With Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Noninferiority Clinical Trial, Diabetes Therapy (2023)

25. Eight Weeks of Vitamin C Supplementation Restores the Lost Correlation Between Serum Leptin and C-Reactive Protein (Crp) in Patients With Type 2 Diabetes; a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Clinical Trial, Current Pharmaceutical Design (2023)

26. Evaluation of Important Human Cyp450 Isoforms and P-Glycoprotein Phenotype Changes and Genotype in Type 2 Diabetic Patients, Before and After Intensifying Treatment Regimen Using Geneva Cocktail, Basic and Clinical Pharmacology and Toxicology (2023)

27. Fibrosis Score 4 Index Has an Independent Relationship With Coronary Artery Diseases in Patients With Metabolic-Associated Fatty Liver Disease, Diabetology and Metabolic Syndrome (2023)

28. Glycemic Profile Variability: An Independent Risk Factor for Diabetic Neuropathy in Patients With Type 2 Diabetes, Primary Care Diabetes (2023)

29. Incident Type 2 Diabetes Attributable to Suboptimal Diet in 184 Countries, Nature Medicine (2023)

30. Incident Type 2 Diabetes Attributable to Suboptimal Diet in 184 Countries, Nature Medicine (2023)

31. Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis, Iranian Journal of Medical Sciences (2023)

32. Lipid Accumulation Product (Lap) Index for the Diagnosis of Nonalcoholic Fatty Liver Disease (Nafld): A Systematic Review and Meta-Analysis, Lipids in Health and Disease (2023)

33. Lipid Profile, Ox-Ldl, and Lcat Activity in Patients With Endometrial Carcinoma and Type 2 Diabetes: The Effect of Concurrent Disease Based on a Case–Control Study, Health Science Reports (2023)

34. Non-Alcoholic Fatty Liver Disease and Incidence of Microvascular Complications of Diabetes in Patients With Type 2 Diabetes: A Prospective Cohort Study, Frontiers in Endocrinology (2023)

35. Serum Lipoprotein(A) and Reclassification of Coronary Heart Disease Risk; Application of Prediction in a Cross-Sectional Analysis of an Ongoing Iranian Cohort, BMC Public Health (2023)

36. Sugar-Sweetened Beverage Intakes Among Adults Between 1990 and 2018 in 185 Countries, Nature Communications (2023)

37. Sugar-Sweetened Beverage Intakes Among Adults Between 1990 and 2018 in 185 Countries, Nature Communications (2023)

38. The Formation of Health-Related Procrastination in Patients With Type-2 Diabetes: A Grounded Theory Research, Frontiers in Psychology (2023)

39. The Lack of Association Between Different Ldl-C Levels and Oxidized Ldl in Patients With Type 2 Diabetes, Chronic Diseases and Translational Medicine (2023)

40. The Trend of Achieving Abc Goals in Patients With Type 2 Diabetes Between 2010-2014 and 2015–2019, Obesity Medicine (2023)

41. Therapeutic Effects of Resveratrol and Omega-3 in Mice Atherosclerosis: Focus on Histopathological Changes, BMC Complementary Medicine and Therapies (2023)

42. Vitamin C Supplementation Lowers Advanced Glycation End Products (Ages) and Malondialdehyde (Mda) in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Food Science and Nutrition (2023)

43. Atherogenic Index of Plasma Is an Independent Predictor of Metabolic-Associated Fatty Liver Disease in Patients With Type 2 Diabetes, European Journal of Medical Research (2022)

44. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite], Eastern Mediterranean Health Journal (2022)

45. Development of an Accreditation System for Evaluating Biomedical Scientific Associations Through a Participatory Process in Iran, Medical Journal of the Islamic Republic of Iran (2022)

46. Diabetes-Related Distress and Its Association With the Complications of Diabetes in Iran, Journal of Diabetes and Metabolic Disorders (2022)

47. Effect of Daily Consumption of Probiotic Yoghurt on Albumin to Creatinine Ratio, Egfr and Metabolic Parameters in Patients With Type 2 Diabetes With Microalbuminuria: Study Protocol for a Randomised Controlled Clinical Trial, BMJ Open (2022)

48. Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes, Diabetes Therapy (2022)

49. Obesity and Diabetic Complications: A Study From the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (Nppcd-2021) Implications for Action on Multiple Scales, Primary Care Diabetes (2022)

50. Predicting Diabetic Nephropathy in Type 2 Diabetic Patients Using Machine Learning Algorithms, Journal of Diabetes and Metabolic Disorders (2022)

51. Quality of Care in Type 2 Diabetes in Iran; a Cross-Sectional Study Using Patient-Level Data, BMC Endocrine Disorders (2022)

52. Response to the Letter to the Editor Concerning the Manuscript, “Uncontrolled Hypertension in Patients With Type 2 Diabetes: What Are the Correlates”, Journal of Clinical Hypertension (2022)

53. The Accuracy of Triglyceride-Glucose (Tyg) Index for the Screening of Metabolic Syndrome in Adults: A Systematic Review and Meta-Analysis, Nutrition# Metabolism and Cardiovascular Diseases (2022)

54. Types of Health-Related Procrastination in Patients With Type-2 Diabetes: A Qualitative Content Analysis, Journal of Diabetes and Metabolic Disorders (2022)

55. Association Between Visit-To-Visit Variability of Glycemic Indices and Lipid Profile and the Incidence of Coronary Heart Disease in Adults With Type 2 Diabetes, Journal of Diabetes and Metabolic Disorders (2021)

56. Correlates of Recurrence-Free Survival in Papillary Thyroid Carcinoma: A Cohort Study in an Iranian Population; [Papiller Tiroid Karsinomunda Nukssuz Sagkalim Ile Iliskili Faktorler: Iran Populasyonunda Bir Kohort Calismasi], Turkish Journal of Endocrinology and Metabolism (2021)

57. Effects of a Mediterranean Diet on the Development of Diabetic Complications: A Longitudinal Study From the Nationwide Diabetes Report of the National Program for Prevention and Control of Diabetes (Nppcd 2016-2020), Maturitas (2021)

58. Improvement in Redox Homeostasis After Cytoreductive Surgery in Colorectal Adenocarcinoma, Oxidative Medicine and Cellular Longevity (2021)

59. Iranian National Clinical Practice Guideline for Exercise in Patients With Diabetes, International Journal of Endocrinology and Metabolism (2021)

60. Ldl/Apo B Ratio Predict Coronary Heart Disease in Type 2 Diabetes Independent of Ascvd Risk Score: A Case-Cohort Study, Nutrition# Metabolism and Cardiovascular Diseases (2021)

61. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)

62. Mapping Routine Measles Vaccination in Low- and Middle-Income Countries, Nature (2021)

63. Prevalence of Diabetes-Associated Autoantibodies Among Patients Presenting With Type 2 Diabetes and Related Metabolic Differences, Primary Care Diabetes (2021)

64. The Challenge of Tuberculosis Diagnosis and Management in the Era of the Covid-19 Pandemic and Diabetes Mellitus, Archives of Clinical Infectious Diseases (2021)

65. The Effect of Vitamin D Deficiency State on Oxidized Low-Density Lipoprotein Alteration in Patients With Type 2 Diabetes, Functional Foods in Health and Disease (2021)

66. Type 1 Diabetic Manifestations in a Young Man Triggered by Covid-19, Clinical Case Reports (2021)

67. Uncontrolled Hypertension in Patients With Type 2 Diabetes: What Are the Correlates?, Journal of Clinical Hypertension (2021)

68. Waist-To-Height Ratio Is a More Accurate Tool for Predicting Hypertension Than Waist-To-Hip Circumference and Bmi in Patients With Type 2 Diabetes: A Prospective Study, Frontiers in Public Health (2021)

69. Advanced Glycation End-Products and Advanced Oxidation Protein Products Levels Are Correlates of Duration of Type 2 Diabetes, Life Sciences (2020)

70. Association Between Dietary Inflammatory Index and Components of Metabolic Syndrome, Journal of Cardiovascular and Thoracic Research (2020)

71. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)

72. Author Correction: Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017 (Nature Medicine, (2020), 26, 5, (750-759), 10.1038/S41591-020-0807-6), Nature Medicine (2020)

73. Barriers to Initiation of Insulin Therapy in Poorly Controlled Type 2 Diabetes Based on Self-Determination Theory; [Obstacles Face a La Mise En Place De L’Insulinotherapie Dans Le Diabete De Type 2 Mal Controle Selon La Theorie De L’Autodetermination], Eastern Mediterranean Health Journal (2020)

74. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)

75. Department of Error: Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000–17: Analysis for the Global Burden of Disease Study 2017 (The Lancet (2020) 395(10239) (1779–1801), (S0140673620301148), (10.1016/S0140-6736(20)30114-8)), The Lancet (2020)

76. Determinants of Glycemic Control: Phase 2 Analysis From Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2018), Primary Care Diabetes (2020)

77. Diabetes Management During the Covid-19 Pandemic: An Iranian Expert Opinion Statement, Archives of Iranian Medicine (2020)

78. Dpp4 Inhibitors in the Management of Hospitalized Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials, Advances in Therapy (2020)

79. Effects of Zinc, Vitamin D, and Their Co-Supplementation on Mood, Serum Cortisol, and Brain-Derived Neurotrophic Factor in Patients With Obesity and Mild to Moderate Depressive Symptoms: A Phase Ii, 12-Wk, 2 × 2 Factorial Design, Double-Blind, Randomized, Placebo-Controlled Trial, Nutrition (2020)

80. Evaluating the Effect of Type 2 Diabetes Mellitus on Cyp450 Enzymes and P-Gp Activities, Before and After Glycemic Control: A Protocol for a Case–Control Pharmacokinetic Study, MethodsX (2020)

81. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)

82. Five Insights From the Global Burden of Disease Study 2019, The Lancet (2020)

83. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

84. Global Age-Sex-Specific Fertility, Mortality, Healthy Life Expectancy (Hale), and Population Estimates in 204 Countries and Territories, 1950–2019: A Comprehensive Demographic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

85. Global and Regional Estimates and Projections of Diabetes-Related Health Expenditure: Results From the International Diabetes Federation Diabetes Atlas, 9Th Edition, Diabetes Research and Clinical Practice (2020)

86. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

87. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

88. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

89. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

90. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017, Circulation (2020)

91. Global, Regional, and National Burden of Chronic Kidney Disease, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)

92. Inadequate Achievement of Abc Goals (Hba1c, Blood Pressure, Ldl-C) Among Patients With Type 2 Diabetes in an Iranian Population, 2012–2017, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2020)

93. Lecithin-Cholesterol Acyltransferase (Lcat) Activity Is Lower in Patients With Type 2 Diabetes in the Presence of Metabolic Syndrome, Bioactive Compounds in Health and Disease (2020)

94. Lipoprotein(A) and Apolipoproteins As Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study, Canadian Journal of Diabetes (2020)

95. Lp(A) and Apo-Lipoproteins As Predictors for Micro- and Macrovascular Complications of Diabetes: A Case-Cohort Study, Nutrition# Metabolism and Cardiovascular Diseases (2020)

96. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)

97. Mapping Geographical Inequalities in Childhood Diarrhoeal Morbidity and Mortality in Low-Income and Middle-Income Countries, 2000-17: Analysis for the Global Burden of Disease Study 2017, The Lancet (2020)

98. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)

99. Mapping Geographical Inequalities in Oral Rehydration Therapy Coverage in Low-Income and Middle-Income Countries, 2000-17, The Lancet Global Health (2020)

100. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)

101. Mapping Local Patterns of Childhood Overweight and Wasting in Low- and Middle-Income Countries Between 2000 and 2017, Nature Medicine (2020)

102. Measuring Universal Health Coverage Based on an Index of Effective Coverage of Health Services in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

103. Measuring Universal Health Coverage Based on an Index of Effective Coverage of Health Services in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)

104. Neutrophil Gelatinase-Associated Lipocalin and Retinol-Binding Protein-4 As Biomarkers for Diabetic Kidney Disease, Kidney and Blood Pressure Research (2020)

105. Nitric Oxide and Tnf-Α Are Correlates of Diabetic Retinopathy Independent of Hs-Crp and Hba1c, Endocrine (2020)

106. Serum Hsp70 Level in Patients With Endometrial Cancer With and Without Diabetes, Gynecological Endocrinology (2020)

107. Serum Irisin Levels in Metabolically Healthy Versus Metabolically Unhealthy Obesity: A Case-Control Study, Medical Journal of the Islamic Republic of Iran (2020)

108. Smoking and Diabetes Control in Adults With Type 1 and Type 2 Diabetes: A Nationwide Study From the 2018 National Program for Prevention and Control of Diabetes of Iran, Canadian Journal of Diabetes (2020)

109. The Effects of a Melissa Officinalis L. Based Product on Metabolic Parameters in Patients With Type 2 Diabetes Mellitus: A Randomized Double-Blinded Controlled Clinical Trial, Journal of Complementary and Integrative Medicine (2020)

110. The Urgent Need for Integrated Science to Fight Covid-19 Pandemic and Beyond, Journal of Translational Medicine (2020)

111. The Urgent Need for Integrated Science to Fight Covid-19 Pandemic and Beyond, Journal of Translational Medicine (2020)

112. Adiponectin: An Indicator for Metabolic Syndrome, Iranian Journal of Public Health (2019)

113. Association of Extracellular Heat Shock Protein 70 and Insulin Resistance in Type 2 Diabetes; Independent of Obesity and C-Reactive Protein, Cell Stress and Chaperones (2019)

114. Association of Non-Alcoholic Fatty Liver Disease With Microvascular Complications of Type 2 Diabetes, Primary Care Diabetes (2019)

115. Associations of Serum S100b and S100p With the Presence and Classification of Diabetic Peripheral Neuropathy in Adults With Type 2 Diabetes: A Case-Cohort Study, Canadian Journal of Diabetes (2019)

116. Cardiovascular and Renal Benefits of Sglt2 Inhibitors: A Narrative Review, International Journal of Endocrinology and Metabolism (2019)

117. Comparing Serum Concentration of Spexin Among Patients With Metabolic Syndrome, Healthy Overweight/Obese, and Normal-Weight Individuals, Medical Journal of the Islamic Republic of Iran (2019)

118. Comparison of Primary Versus Secondary Prevention of Cardiovascular Disease in Patients With Type2 Diabetes: Focus on Achievement of Abc Goals, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2019)

119. Definition of an Oxidative Stress Status by Combined Assessment of Malondialdehyde and Oxidized-Ldl: A Study in Patients With Type2 Diabetes and Control, Meta Gene (2019)

120. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)

121. Erratum: Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)), The Lancet (2019)

122. Gender Difference in Plasminogen Activator Inhibitor-1 Activity in Patients With Type 2 Diabetes With and Without Albuminuria, a Matched Case-Control Study, Functional Foods in Health and Disease (2019)

123. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)

124. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)

125. Global, Regional, and National Burden of Suicide Mortality 1990 to 2016: Systematic Analysis for the Global Burden of Disease Study 2016, BMJ (Online) (2019)

126. Global, Regional, and National Burden of Traumatic Brain Injury and Spinal Cord Injury, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)

127. Health Effects of Dietary Risks in 195 Countries, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2019)

128. Inflammatory, Oxidative Stress and Anti-Oxidative Markers in Patients With Endometrial Carcinoma and Diabetes, Cytokine (2019)

129. Insulin Pen Use and Diabetes Treatment Goals: A Study From Iran Steps 2016 Survey, PLoS ONE (2019)

130. Leptin, Hs-Crp and Homa-Ir in Patients With Type 2 Diabetes: The Role of Different Levels of Vitamin D Deficiency, Functional Foods in Health and Disease (2019)

131. Loss of Inverse Association Between Framingham Risk Score and Estimated Glomerular Filtration Rate in Moderate to Severe Diabetic Kidney Disease, Archives of Iranian Medicine (2019)

132. Patient and Physician Preferences for Type 2 Diabetes Medications: A Systematic Review, Journal of Diabetes and Metabolic Disorders (2019)

133. Role of Type 2 Diabetes and Hemodialysis in Serum Adipolin Concentrations: A Preliminary Study, Hemodialysis International (2019)

134. Sitagliptin Vs. Pioglitazone As Add-On Treatments in Patients With Uncontrolled Type 2 Diabetes on the Maximal Dose of Metformin Plus Sulfonylurea, Journal of Endocrinological Investigation (2019)

135. The Global, Regional, and National Burden of Colorectal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)

136. The Global, Regional, and National Burden of Pancreatic Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet Gastroenterology and Hepatology (2019)

137. Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2018)

138. Alcohol Use and Burden for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2018)

139. Ambulatory Blood Pressure Monitoring and Diabetes Complications: Targeting Morning Blood Pressure Surge and Nocturnal Dipping, Medicine (United States) (2018)

140. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study, Annals of Nutrition and Metabolism (2018)

141. Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes With Nephropathy, American Journal of the Medical Sciences (2018)

142. Body Composition in Healthy Obese/Overweight and Normal Weight Subjects Compared to Patients With Metabolic Syndrome, Journal of Nutrition and Food Security (2018)

143. Depressive Symptoms Among Metabolically Healthy and Unhealthy Overweight/Obese Individuals: A Comparative Study, Medical Journal of the Islamic Republic of Iran (2018)

144. Early Insulin Glargine Initiation in Iranian People With Uncontrolled Type 2 Diabetes: Glycemic Control, and Adverse Events, Acta Medica Iranica (2018)

145. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)

146. Erratum: Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1736–1788)(S0140673618322037)(10.1016/S0140-6736(18)32203-7)), The Lancet (2018)

147. Gabric Diabetes School: An Innovative Education Centre for People With Diabetes; [Gabric, L’Ecole Du Diabete: Un Centre D’Education Pour Diabetiques Innovant], Eastern Mediterranean Health Journal (2018)

148. Global Mortality From Firearms, 1990-2016, JAMA - Journal of the American Medical Association (2018)

149. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

150. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

151. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

152. Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

153. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

154. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

155. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

156. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

157. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

158. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

159. Intentional Injuries in the Eastern Mediterranean Region, 1990–2015: Findings From the Global Burden of Disease 2015 Study, International Journal of Public Health (2018)

160. Intercellular Adhesion Molecule-1 in Diabetic Patients With and Without Microalbuminuria, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2018)

161. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

162. Measuring Progress From 1990 to 2017 and Projecting Attainment to 2030 of the Health-Related Sustainable Development Goals for 195 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

163. National Prevalence of Self-Reported Coronary Heart Disease and Chronic Stable Angina Pectoris: Factor Analysis of the Underlying Cardiometabolic Risk Factors in the Surfncd-2011, Global Heart (2018)

164. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

165. Population and Fertility by Age and Sex for 195 Countries and Territories, 1950–2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)

166. Pulse Pressure and Diabetes Treatments: Blood Pressure and Pulse Pressure Difference Among Glucose Lowering Modality Groups in Type 2 Diabetes, Medicine (United States) (2018)

167. All-Cause and Cardiovascular Mortality Following Treatment With Metformin or Glyburide in Patients With Type 2 Diabetes Mellitus, Archives of Iranian Medicine (2017)

168. Association of Human Leukocyte Antigens Class I & Ii With Graves’ Disease in Iranian Population, Iranian Journal of Immunology (2017)

169. Association of Peripheral Nesfatin-1 With Early Stage Diabetic Nephropathy, Pathophysiology (2017)

170. Cardiovascular Risk Assessment by Frs and Score in Iranian Adult Population, Journal of Diabetes and Metabolic Disorders (2017)

171. Circulating Levels of Fibroblast Growth Factor 21 in Early-Stage Diabetic Kidney Disease, Irish Journal of Medical Science (2017)

172. Conflicting Interactions of Apolipoprotein a and High Density Lipoprotein Cholesterol With Microvascular Complications of Type 2 Diabetes, Diabetes Research and Clinical Practice (2017)

173. Depression Improvement Among Patients With Hiv and Endocrine Dysfunction After Hormone Therapy, Iranian Red Crescent Medical Journal (2017)

174. Diabetes in Iran: Prospective Analysis From First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (Nppcd-2016), Scientific Reports (2017)

175. Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale) in Iran and Its Neighboring Countries, 1990–2015: Findings From Global Burden of Disease Study 2015, Archives of Iranian Medicine (2017)

176. Distributions of High-Sensitivity C-Reactive Protein, Total Cholesterol-Hdl Ratio and 10-Year Cardiovascular Risk: National Population-Based Study, Acta Medica Iranica (2017)

177. Erratum: Global, Regional, and National Levels of Maternal Mortality, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)), The Lancet (2017)

178. Erratum: Global, Regional, National, and Selected Subnational Levels of Stillbirths, Neonatal, Infant, and Under-5 Mortality, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6)), The Lancet (2017)

179. Family History of Diabetes and the Risk of Coronary Heart Disease in People With or Without Type 2 Diabetes, Diabetes and Metabolism (2017)

180. Global, Regional, and National Age-Sex Specific Mortality for 264 Causes of Death, 1980–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)

181. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015, Journal of the American College of Cardiology (2017)

182. Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)

183. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 333 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)

184. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)

185. Global, Regional, and National Under-5 Mortality, Adult Mortality, Age-Specific Mortality, and Life Expectancy, 1970-2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet (2017)

186. Health Effects of Overweight and Obesity in 195 Countries Over 25 Years, New England Journal of Medicine (2017)

187. Healthcare Access and Quality Index Based on Mortality From Causes Amenable to Personal Health Care in 195 Countries and Territories, 1990-2015: A Novel Analysis From the Global Burden of Disease Study 2015, The Lancet (2017)

188. Inverse Association of Peripheral Orexin-A With Insulin Resistance in Type 2 Diabetes Mellitus: A Randomized Clinical Trial, Review of Diabetic Studies (2017)

189. Measuring Progress and Projecting Attainment on the Basis of Past Trends of the Health-Related Sustainable Development Goals in 188 Countries: An Analysis From the Global Burden of Disease Study 2016, The Lancet (2017)

190. Metabolic Syndrome Patients Have Lower Levels of Adropin When Compared With Healthy Overweight/Obese and Lean Subjects, American Journal of Men's Health (2017)

191. Muscle Perfusion Scan for Prediction of Anticipated Diabetic Foot Ulceration, Iranian Journal of Nuclear Medicine (2017)

192. Non-High-Density Lipoprotein Fractions Are Strongly Associated With the Presence of Metabolic Syndrome Independent of Obesity and Diabetes: A Population-Based Study Among Iranian Adults, Journal of Diabetes and Metabolic Disorders (2017)

193. Prevalence and Years Lived With Disability of 310 Diseases and Injuries in Iran and Its Neighboring Countries, 1990–2015: Findings From Global Burden of Disease Study 2015, Archives of Iranian Medicine (2017)

194. Prevalence of Metabolic Syndrome in Iran: A 2011 Update, Journal of Diabetes (2017)

195. Retinal Nerve Fibre Layer Thickness Is Reduced in Metabolic Syndrome, Diabetic Medicine (2017)

196. Serum 25-Hydroxyvitamin D, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes, Nutrition# Metabolism and Cardiovascular Diseases (2017)

197. The Effect of Coenzyme Q10 Supplementation on Circulating Levels of Novel Adipokine Adipolin/Ctrp12 in Overweight and Obese Patients With Type 2 Diabetes, Experimental and Clinical Endocrinology and Diabetes (2017)

198. The Prevalence of Metabolic Syndrome and Different Obesity Phenotype in Iranian Male Military Personnel, American Journal of Men's Health (2017)

199. Trend of Socio-Demographic Index and Mortality Estimates in Iran and Its Neighbors, 1990–2015; Findings of the Global Burden of Diseases 2015 Study, Archives of Iranian Medicine (2017)

200. Absence of a Positive Correlation Between Crp and Leptin in Rheumatoid Arthritis, Heliyon (2016)

201. Awareness, Treatment and Control of Pre-Hypertension, and Hypertension Among Adults in Iran, Archives of Iranian Medicine (2016)

202. Biphasic Insulin Aspart 30 Vs. Nph Plus Regular Human Insulin in Type 2 Diabetes Patients; a Cost-Effectiveness Study, BMC Endocrine Disorders (2016)

203. Changing Correlations Among Adma, No and Hs-Crp in Normoalbuminuric and Microalbuminuric Patients With Type 2 Diabetes, Meta Gene (2016)

204. Complex Association of Serum Alanine Aminotransferase With the Risk of Future Cardiovascular Disease in Type 2 Diabetes, Atherosclerosis (2016)

205. Contribution of Vitamin D Deficiency to the Risk of Coronary Heart Disease in Subjects With Essential Hypertension, Atherosclerosis (2016)

206. Diet Quality in Obese/Overweight Individuals With/Without Metabolic Syndrome Compared to Normal Weight Controls, Medical Journal of the Islamic Republic of Iran (2016)

207. Estimates of Global, Regional, and National Incidence, Prevalence, and Mortality of Hiv, 1980–2015: The Global Burden of Disease Study 2015, The Lancet HIV (2016)

208. Fasting Hyperinsulinaemia and 2-H Glycaemia Predict Coronary Heart Disease in Patients With Type 2 Diabetes, Diabetes and Metabolism (2016)

209. Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)

210. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 315 Diseases and Injuries and Healthy Life Expectancy (Hale), 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)

211. Global, Regional, and National Levels of Maternal Mortality, 1990–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)

212. Global, Regional, and National Life Expectancy, All-Cause Mortality, and Cause-Specific Mortality for 249 Causes of Death, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)

213. Global, Regional, National, and Selected Subnational Levels of Stillbirths, Neonatal, Infant, and Under-5 Mortality, 1980–2015: A Systematic Analysis for the Global Burden of Disease Study 2015, The Lancet (2016)

214. Hdl Cholesterol As a Residual Risk Factor for Vascular Events and All-Cause Mortality in Patients With Type 2 Diabetes, Diabetes Care (2016)

215. Health in Times of Uncertainty in the Eastern Mediterranean Region, 1990–2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet Global Health (2016)

216. Hypertension and Mortality in the Golestan Cohort Study: A Prospective Study of 50 000 Adults in Iran, Journal of Human Hypertension (2016)

217. Measuring the Health-Related Sustainable Development Goals in 188 Countries: A Baseline Analysis From the Global Burden of Disease Study 2015, The Lancet (2016)

218. Non-Linear Contribution of Serum Vitamin D to Symptomatic Diabetic Neuropathy: A Case-Control Study, Diabetes Research and Clinical Practice (2016)

219. Nonlinear Relation Between Pulse Pressure and Coronary Heart Disease in Patients With Type 2 Diabetes or Hypertension, Journal of Hypertension (2016)

220. Oxidized Low-Density Lipoprotein (Ox-Ldl) to Ldl Ratio (Ox-Ldl/Ldl) and Ox-Ldl to High-Density Lipoprotein Ratio (Ox-Ldl/Hdl): Are They Accurate Biomarkers of Type 2 Diabetes Mellitus?, Clinical Laboratory (2016)

221. Positive Correlation of Serum Adiponectin With Lipid Profile in Patients With Type 2 Diabetes Mellitus Is Affected by Metabolic Syndrome Status, Archives of Iranian Medicine (2016)

222. Raised Serum 25-Hydroxyvitamin D Levels in Patients With Active Diabetic Foot Ulcers, British Journal of Nutrition (2016)

223. Serum Fibroblast Growth Factor 21 Concentrations in Type 2 Diabetic Retinopathy Patients; [Dosage Serique Du Facteur De Croissance Des Fibroblastes 21 Chez Les Patients Atteints De Retinopathie Diabetique De Type 2], Annales d'Endocrinologie (2016)

224. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care 2016;39:1364-1370, Diabetes Care (2016)

225. The Lost Correlation Between Heat Shock Protein 70 (Hspa1a) and Plasminogen Activator Inhibitor-1 in Patients With Type 2 Diabetes and Albuminuria, Cell Stress and Chaperones (2016)

226. Type 2 Diabetes: Model of Factors Associated With Glycemic Control, Canadian Journal of Diabetes (2016)

227. Abdominal Obesity and Gestational Diabetes: The Interactive Role of Magnesium, Magnesium Research (2015)

228. An Inverse Association Between Serum Vitamin D Levels With the Presence and Severity of Impaired Nerve Conduction Velocity and Large Fiber Peripheral Neuropathy in Diabetic Subjects, Neurological Sciences (2015)

229. Assessment of Serum 25-Hydroxy Vitamin D Improves Coronary Heart Disease Risk Stratification in Patients With Type 2 Diabetes, American Heart Journal (2015)

230. Association of Osteoprotegerin With Peripheral Artery Disease in Patients With Type 2 Diabetes, Archives of Cardiovascular Diseases (2015)

231. Associations of Small Dense Low-Density Lipoprotein and Adiponectin With Complications of Type 2 Diabetes, Endocrine Research (2015)

232. Changes in Leukocyte Subpopulations With Decline in Glomerular Filtrationrate in Patients With Type 2 Diabetes, Acta Medica Iranica (2015)

233. Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (Rs4646994) and Vegf Polymorphism (+405G/C; Rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes, Iranian Red Crescent Medical Journal (2015)

234. Comparative Effects of Metformin and Pioglitazone on Fetuin-A and Osteoprotegerin Concentrations in Patients With Newly Diagnosed Diabetes: A Randomized Clinical Trial, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2015)

235. Complementary and Alternative Medicine for the Treatment of Obesity: A Critical Review, International Journal of Endocrinology and Metabolism (2015)

236. Diabetes Care in Iran: Where We Stand and Where We Are Headed, Annals of Global Health (2015)

237. Evaluation of Plasma Mmp-8, Mmp-9 and Timp-1 Identifies Candidate Cardiometabolic Risk Marker in Metabolic Syndrome: Results From Double-Blinded Nested Case-Control Study, Metabolism: Clinical and Experimental (2015)

238. Folate Therapy Improves the Stress-To-Rest Mean Lv Volume Ratio in Myocardial Perfusion Imaging in Patients With Diabetes, Annals of Nuclear Medicine (2015)

239. Global, Regional, and National Age-Sex Specific All-Cause and Cause-Specific Mortality for 240 Causes of Death, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)

240. Global, Regional, and National Comparative Risk Assessment of 79 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)

241. Global, Regional, and National Disability-Adjusted Life Years (Dalys) for 306 Diseases and Injuries and Healthy Life Expectancy (Hale) for 188 Countries, 1990-2013: Quantifying the Epidemiological Transition, The Lancet (2015)

242. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 301 Acute and Chronic Diseases and Injuries in 188 Countries, 1990-2013: A Systematic Analysis for the Global Burden of Disease Study 2013, The Lancet (2015)

243. Pulse Pressure Does Not Predict the Response of Diabetic Nephropathy to Glucose-Lowering Therapy, Diabetes and Vascular Disease Research (2015)

244. Reduction in Asymmetric Dimethylarginine Plasma Levels by Coenzyme Q10 Supplementation in Patients With Type 2 Diabetes Mellitus, Minerva Endocrinologica (2015)

245. Relationship Between Neuropathy With Pressure on Foot in Diabetic Patients, Biosciences Biotechnology Research Asia (2015)

246. Relationship Between Neuropathy With Pressure on Foot in Diabetic Patients, Biomedical and Pharmacology Journal (2015)

247. Revising the Fasting Glucose Threshold for Detection of Cardiovascular Risk Factors: Analysing Two Representative Population-Based Studies of More Than 50000 Iranians in 3 Years: The National Survey of Risk Factors for Non-Communicable Diseases of Iran, Annals of Human Biology (2015)

248. The Comparative Effect of Pioglitazone and Metformin on Serum Osteoprotegerin, Adiponectin and Intercellular Adhesion Molecule Concentrations in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Clinical Trial, Experimental and Clinical Endocrinology and Diabetes (2015)

249. The Global Burden of Cancer 2013, JAMA Oncology (2015)

250. Vitamin D Deficiency Is Associated With Insulin Resistance in Nondiabetics and Reduced Insulin Production in Type 2 Diabetics, Hormone and Metabolic Research (2015)

251. Appropriate Definition of Metabolic Syndrome Among Iranian Adults: Report of the Iranian National Committee of Obesity, Archives of Iranian Medicine (2010)

252. Appropriate Waist Circumference Cut-Off Points Among Iranian Adults: The First Report of the Iranian National Committee of Obesity, Archives of Iranian Medicine (2010)

253. The Safety and Efficacy of Biphasic Insulin Aspart 30 (Biasp 30) in Iranians With Type 2 Diabetes: An Open-Label, Non-Randomised, Multi-Centre Observational Study - the Iran Subgroup of the Improve™ Study, Endokrynologia Polska (2010)